| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.84B | 25.81B | 26.41B | 28.50B | 24.63B | 24.12B |
| Gross Profit | 2.43B | 2.16B | 1.86B | 1.98B | 1.78B | 1.69B |
| EBITDA | 1.76B | 1.78B | 1.41B | 1.54B | 1.61B | 1.44B |
| Net Income | 852.00M | 838.00M | 1.01B | 793.00M | 936.00M | 613.00M |
Balance Sheet | ||||||
| Total Assets | 20.82B | 18.38B | 18.26B | 21.41B | 19.32B | 15.84B |
| Cash, Cash Equivalents and Short-Term Investments | 3.06B | 2.29B | 2.47B | 3.16B | 2.96B | 2.64B |
| Total Debt | 5.60B | 4.15B | 3.75B | 4.20B | 4.75B | 4.34B |
| Total Liabilities | 15.70B | 13.38B | 12.93B | 15.70B | 15.12B | 12.40B |
| Stockholders Equity | 5.12B | 5.00B | 5.33B | 5.35B | 4.13B | 3.44B |
Cash Flow | ||||||
| Free Cash Flow | 1.16B | 1.07B | 796.00M | 315.00M | 581.00M | -207.00M |
| Operating Cash Flow | 1.71B | 1.50B | 1.33B | 950.00M | 1.02B | 144.00M |
| Investing Cash Flow | -669.00M | -838.00M | -492.00M | -604.00M | -951.00M | -202.00M |
| Financing Cash Flow | -343.00M | -821.00M | -1.66B | 2.00M | 280.00M | 743.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $24.07B | 23.76 | 16.83% | ― | 0.77% | 0.51% | |
74 Outperform | $5.43B | 24.74 | 12.39% | ― | 1.82% | 56.52% | |
69 Neutral | $28.05B | 31.64 | 58.99% | 0.14% | 13.18% | -38.37% | |
66 Neutral | $7.08B | 42.40 | 9.86% | ― | 7.40% | 13.79% | |
63 Neutral | $15.26B | 43.86 | 7.46% | ― | -0.86% | -75.37% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | $17.02B | 30.16 | 6.90% | 0.43% | -8.96% | -30.29% |